97 results on '"Pappaccogli, M."'
Search Results
2. PREVALENCE AND NATURE OF PREGNANCY-RELATED COMPLICATIONS IN PATIENTS WITH FIBROMUSCULAR DYSPLASIA IN THE EUROPEAN / INTERNATIONAL FMD REGISTRY
- Author
-
Pappaccogli, M., Prejbisz, A., Ciurică, S., Bruno, R.M., Aniszczuk-Hybiak, A., Debiève, F., Delmotte, P., Di Monaco, S., Jarraya, F., Gordin, D., Kosiński, P., Maas, A., Minuz, P., Toubiana, L., Vinck, W., de Leeuw, P., Van der Niepen, P., Januszewicz, A., and Persu, A.
- Published
- 2019
- Full Text
- View/download PDF
3. THE EUROPEAN / INTERNATIONAL FIBROMUSCULAR DYSPLASIA REGISTRY: MAIN FINDINGS IN THE FIRST THOUSAND PATIENTS
- Author
-
Pappaccogli, M., Di Monaco, S., Aparicio, L.S., Azizi, M., Bruno, R.M., de Leeuw, P.W., Delmotte, P., Gordin, D., Iwashima, Y., Januszewicz, A., Kroon, A.A., Lorthioir, A., Poch, E., Prejbisz, A., Seinturier, C., Toubiana, L., van der Niepen, P., Wang, J., Claude Wautrecht, J., Persu, A., and on behalf of the European/International Fibromuscular Dysplasia Initiative Investigators
- Published
- 2019
- Full Text
- View/download PDF
4. PREDICTORS OF EVENTUAL BLOOD PRESSURE CONTROL IN PATIENTS WITH RESISTANT HYPERTENSION AFTER INTENSIVE MANAGEMENT IN TWO EXPERT CENTRES: THE BRUSSELS-TORINO EXPERIENCE
- Author
-
Pappaccogli, M., Di Monaco, S., Mg. Georges, C., Petit, G., Eula, E., Lengelé, J.P., Renkin, J., Severino, F., De Timary, P., Rabbia, F., and Persu, A.
- Published
- 2019
- Full Text
- View/download PDF
5. HOW GOOD ARE PHYSICIANS AT MEASURING BLOOD PRESSURE IN DIALYSIS? - PATIENT VERSUS PHYSICIAN VIEW
- Author
-
Pappaccogli, M., Labriola, L., Rossignol, P., Alexandrou, M.E., Avdelidou, A., Schoina, M., Bikos, A., Karpetas, A., Panou, E., Papoulidou, F., Pruijm, M., Raptis, V., Saudan, P., Sarafidis, P., Persu, A., and Wuerzner, G.
- Published
- 2019
- Full Text
- View/download PDF
6. WHEN TO SEARCH FOR CEREBROVASCULAR LESIONS IN PATIENTS WITH RENAL ARTERY FIBROMUSCULAR DYSPLASIA: HINTS FROM THE ARCADIA-POL STUDY
- Author
-
Pappaccogli, M., Warchol-Celinska, E., Swiatlowski, L., Prejbisz, A., Elzbieta, F., Katarzyna, J.P., Talarowska, P., Januszewicz, M., Dobrowolski, P., Klisiewicz, A., Michalowska, I., Kadziela, J., Witkowski, A., Tykarski, A., Falkowski, A., Januszewicz, A., Szczerbo-Trojanowska, M., and Persu, A.
- Published
- 2019
- Full Text
- View/download PDF
7. DISTINCTIVE FEATURES OF PATIENTS DIAGNOSED WITH FIBROMUSCULAR DYSPLASIA (FMD) AT AN OLDER AGE: A REPORT FROM THE EUROPEAN / INTERNATIONAL FMD REGISTRY
- Author
-
Pappaccogli, M., Di Monaco, S., Amar, L., Aparicio, L.S., Azizi, M., Bruno, R.M., de Leeuw, P.W., Delmotte, P., Iwashima, Y., Januszewicz, A., Kroon, A.A., Poch, E., Prejbisz, A., Seinturier, C., Tikkanen, I., Toubiana, L., Van der Niepen, P., Scoppettuolo, P., Xu, J., Persu, A., and on behalf of the European/International Fibromuscular Dysplasia Initiative Investigators
- Published
- 2019
- Full Text
- View/download PDF
8. GENETIC STUDY OF PHACTR1 AND FIBROMUSCULAR DYSPLASIA, META-ANALYSIS AND EFFECTS ON CLINICAL FEATURES OF PATIENTS: THE ARCADIA-POL STUDY
- Author
-
Warchol-Celinska, E., Berrandou, T., Prejbisz, A., Georges, A., Dupré, D., Januszewicz, M., Florczak, E., Jozwik-Plebanek, K., Piwonski, J., Drygas, W., Dobrowolski, P., Kabat, M., Szczerbo-Trojanowska, M., Kowalczyk, K., Pappaccogli, M., Persu, A., Plouin, P.-F., Jeunemaitre, X., Januszewicz, A., and Bouatia-Naji, N.
- Published
- 2019
- Full Text
- View/download PDF
9. VISCERAL ARTERY FIBROMUSCULAR DYSPLASIA – CLINICAL PRESENTATION AND VASCULAR BED INVOLVEMENT IN THE ARCADIA-POL STUDY
- Author
-
Warchol-Celinska, E., Pappaccogli, M., Jozwik-Plebanek, K., Prejbisz, A., Januszewicz, M., Michalowska, I., Florczak, E., Dobrowolski, P., Kadziela, J., Kowalczyk, K., Talarowska, P., Madej, K., Nazarewski, S., Zieniewicz, K., Soplinska, A., Pieluszczak, K., Kabat, M., Klisiewicz, A., Persu, A., and Januszewicz, A.
- Published
- 2019
- Full Text
- View/download PDF
10. The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients
- Author
-
Pappaccogli, M., Pappaccogli, M., Di Monaco, S., Warchol-Celinska, E., Lorthioir, A., Amar, L., Aparicio, L.S., Beauloye, C., Bruno, R.M., Chenu, P., de Leeuw, P., De Backer, T., Delmotte, P., Dika, Z., Gordin, D., Heuten, H., Iwashima, Y., Krzesinski, J.M., Kroon, A.A., Mazzolai, L., Poch, E., Sarafidis, P., Seinturier, C., Spiering, W., Toubiana, L., Van der Niepen, P., van Twist, D., Visona, A., Wautrecht, J.C., Witowicz, H., Xu, J.Z., Prejbisz, A., Januszewicz, A., Azizi, M., Persu, A., European/International FMD Registry and Initiative (FEIRI), Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH), Pappaccogli, M., Pappaccogli, M., Di Monaco, S., Warchol-Celinska, E., Lorthioir, A., Amar, L., Aparicio, L.S., Beauloye, C., Bruno, R.M., Chenu, P., de Leeuw, P., De Backer, T., Delmotte, P., Dika, Z., Gordin, D., Heuten, H., Iwashima, Y., Krzesinski, J.M., Kroon, A.A., Mazzolai, L., Poch, E., Sarafidis, P., Seinturier, C., Spiering, W., Toubiana, L., Van der Niepen, P., van Twist, D., Visona, A., Wautrecht, J.C., Witowicz, H., Xu, J.Z., Prejbisz, A., Januszewicz, A., Azizi, M., Persu, A., European/International FMD Registry and Initiative (FEIRI), and Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH)
- Abstract
Aims Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enrolled 1022 patients from 22 countries. We present their characteristics according to disease subtype, age and gender, as well as predictors of widespread disease, aneurysms and dissections.Methods and results All patients diagnosed with FMD (string-of-beads or focal stenosis in at least one vascular bed) based on computed tomography angiography, magnetic resonance angiography, and/or catheter-based angiography were eligible. Patients were predominantly women (82%) and Caucasians (88%). Age at diagnosis was 46 +/- 16 years (12% >= 65 years old), 86% were hypertensive, 72% had multifocal, and 57% multivessel FMD. Compared to patients with multifocal FMD, patients with focal FMD were younger, more often men, had less often multivessel FMD but more revascularizations. Compared to women with FMD, men were younger, had more often focal FMD and arterial dissections. Compared to younger patients with FMD, patients >= 65 years old had more often multifocal FMD, lower estimated glomerular filtration rate and more atherosclerotic lesions. Independent predictors of multivessel FMD were age at FMD diagnosis, stroke, multifocal subtype, presence of aneurysm or dissection, and family history of FMD. Predictors of aneurysms were multivessel and multifocal FMD. Predictors of dissections were age at FMD diagnosis, male gender, stroke, and multivessel FMD.Conclusions The European/International FMD Registry allowed large-scale characterization of distinct profiles of patients with FMD and, more importantly, identification of a unique set of independent predictors of widespread disease, aneurysms and dissections, paving the way for targeted screening, management, and follow-up of FMD.
- Published
- 2021
11. Pregnancy-Related Complications in Patients With Fibromuscular Dysplasia: A Report From the European/International Fibromuscular Dysplasia Registry
- Author
-
Pappaccogli, M, Prejbisz, A, Ciurică, S, Bruno, Rm, Aniszczuk-Hybiak, A, Bracalente, I, De Backer, T, Debiève, F, Delmotte, P, Di Monaco, S, Jarraya, F, Gordin, D, Kosiński, P, Kroon, Aa, Maas, Ahem, Marcon, D, Minuz, P, Montagud-Marrahi, E, Pasquet, A, Poch, E, Rabbia, F, Stergiou, Gs, Tikkanen, I, Toubiana, L, Vinck, W, Warchoł-Celińska, E, Van der Niepen, P, de Leeuw, P, Januszewicz, A, Persu, A, European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI) and the Working Group 'Hypertension and the Kidney' of the ESH: Alexandre Persu, Marco, Pappaccogli, Christophe, Beauloye, Patrick, Chenu, Jean-Philippe, Lengelé, Frank, Hammer, Pierre, Goffette, Parla, Astarci, André, Peeters, Robert, Verhelst, Miikka, Vikkula, Patricia Van der Niepen, Frank Van Tussenbroek, Tine De Backer, Sofie, Gevaert, Philippe, Delmotte, Wouter, Vinck, Daniel, T Gordin, Ilkka, Tikkanen, Maarit, Venermo, George, S Stergiou, Rosa Maria Bruno, Stefano, Taddei, Caterina, Romanini, Ilaria, Petrucci, Franco, Rabbia, Silvia Di Monaco, Pietro, Minuz, Mansueto, Giancarlo, DE MARCHI, Sergio, Denise, Marcon, Bram, Kroon, Peter de Leeuw, Andrzej, Januszewicz, Ewa, Warchol-Celinska, Aleksander, Prejbisz, Adam, Witkowski, Helena, Witowicz, Anna, Aniszczuk-Hybiak, Krzysztof, Pieluszczak, Magdalena, Januszewicz, Piotr, Dobrowolski, Esteban, Poch, Enrique, Montagud-Marrahi, Alicia, Molina, Elena, Guillen, Marta, Burrel, Hanen, Chaker, Faiçal, Jarraya, Anita, Mäkelä, Katarzyna, Józwik-Plebanek, Elżbieta, Florczak, Jacek, Kądziela, Clinical sciences, Clinical Pharmacology and Clinical Pharmacy, Nephrology, Laboratoire d'Informatique Médicale et Ingénierie des Connaissances en e-Santé (LIMICS), Université Paris 13 (UP13)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Interne Geneeskunde, MUMC+: MA Alg Interne Geneeskunde (9), and RS: Carim - V02 Hypertension and target organ damage
- Subjects
Gestational hypertension ,medicine.medical_treatment ,Vascular damage Radboud Institute for Health Sciences [Radboudumc 16] ,fibromuscular dysplasia ,Comorbidity ,Fibromuscular dysplasia ,030204 cardiovascular system & hematology ,Aneurysm rupture ,pregnancy-induced ,Renal Artery ,0302 clinical medicine ,Registries ,CARDIOLOGY ,OUTCOMES ,030219 obstetrics & reproductive medicine ,Obstetrics ,WOMEN ,Middle Aged ,EUROPEAN-SOCIETY ,follow-up studies ,3. Good health ,PREVALENCE ,hypertension, pregnancy-induced ,preeclampsia ,pregnancy ,Lower prevalence ,cardiovascular system ,Premature Birth ,Female ,Adult ,medicine.medical_specialty ,hypertension ,Revascularization ,DIAGNOSIS ,CLASSIFICATION ,Preeclampsia ,Young Adult ,03 medical and health sciences ,ANEURYSM ,Internal Medicine ,medicine ,CORONARY-ARTERY DISSECTION ,MANAGEMENT ,Humans ,In patient ,cardiovascular diseases ,Pregnancy ,business.industry ,medicine.disease ,Pregnancy Complications ,RISK-FACTORS ,[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM] ,business - Abstract
Current literature suggests a higher risk of pregnancy-related complications in patients with renal fibromuscular dysplasia (FMD). The aim of our study was to assess the nature and prevalence of pregnancy-related complications in patients subsequently diagnosed with FMD. A call for participation was sent to centers contributing to the European/International FMD Registry. Patients with at least 1 pregnancy were included. Data on pregnancy were collected through medical files and FMD characteristics through the European/International FMD Registry. Data from 534 pregnancies were obtained in 237 patients. Despite the fact that, in 96% of cases, FMD was not diagnosed before pregnancy, 40% of women (n=93) experienced pregnancy-related complications, mostly gestational hypertension (25%) and preterm birth (20%), while preeclampsia was reported in only 7.5%. Only 1 patient experienced arterial dissection and another patient an aneurysm rupture. When compared with patients without pregnancy-related complications, patients with complicated pregnancies were younger at FMD diagnosis (43 versus 51 years old; P P =0.003) but underwent more often renal revascularization (63% versus 40%, P
- Published
- 2020
12. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic
- Author
-
Kreutz R, Dobrowolski P, Prejbisz A, Algharably E, Bilo G, Creutzig F, Grassi G, Kotsis V, Lovic D, Lurbe E, Modesti P, Pappaccogli M, Parati G, Persu A, Polonia J, Rajzer M, de Timary P, Weber T, Weisser B, Tsioufis K, Mancia G, Januszewicz A, European Society of Hypertension COVID-19 Task Force Review, UCL - SSS/IONS/NEUR - Clinical Neuroscience, UCL - (SLuc) Service de psychiatrie adulte, UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - (SLuc) Service de pathologie cardiovasculaire, Kreutz, R, Dobrowolski, P, Prejbisz, A, Algharably, E, Bilo, G, Creutzig, F, Grassi, G, Kotsis, V, Lovic, D, Lurbe, E, Modesti, P, Pappaccogli, M, Parati, G, Persu, A, Polonia, J, Rajzer, M, de Timary, P, Weber, T, Weisser, B, Tsioufis, K, Mancia, G, and Januszewicz, A
- Subjects
Psychologic stress ,Coronavirus disease 2019 (COVID-19) ,Physiology ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Environmental health ,Pandemic ,Internal Medicine ,Humans ,Medicine ,030212 general & internal medicine ,Risk factor ,Life Style ,Pandemics ,Socioeconomic status ,cardiovascular risk, coronavirus disease 2019, diet, environmental, hypertension, life style, psychological, salt, severe acute respiratory syndrome coronavirus 2 ,SARS-CoV-2 ,business.industry ,Smoking ,COVID-19 ,Diurnal rhythms ,Lifestyle factors ,Blood pressure ,Socioeconomic Factors ,Hypertension ,business ,Cardiology and Cardiovascular Medicine ,Stress, Psychological - Abstract
SUMMARY: The coronavirus disease 2019 (COVID-19) pandemic considerably affects health, wellbeing, social, economic and other aspects of daily life. The impact of COVID-19 on blood pressure (BP) control and hypertension remains insufficiently explored. We therefore provide a comprehensive review of the potential changes in lifestyle factors and behaviours as well as environmental changes likely to influence BP control and cardiovascular risk during the pandemic. This includes the impact on physical activity, dietary patterns, alcohol consumption and the resulting consequences, for example increases in body weight. Other risk factors for increases in BP and cardiovascular risk such as smoking, emotional/psychologic stress, changes in sleep patterns and diurnal rhythms may also exhibit significant changes in addition to novel factors such as air pollution and environmental noise. We also highlight potential preventive measures to improve BP control because hypertension is the leading preventable risk factor for worldwide health during and beyond the COVID-19 pandemic.
- Published
- 2021
13. The European/international fibromuscular dysplasia registry and initiative (FEIRI) - Clinical phenotypes and their predictors based on a cohort of 1000 patients
- Author
-
Pappaccogli, M, Di Monaco, S, Warchoł-Celińska, E, Lorthioir, A, Amar, L, Aparicio, Ls, Beauloye, C, Bruno, Rm, Chenu, P, de Leeuw, P, De Backer, T, Delmotte, P, Dika, Z, Gordin, D, Heuten, H, Iwashima, Y, Krzesinski, Jm, Kroon, Aa, Mazzolai, L, Poch, E, Sarafidis, P, Seinturier, C, Spiering, W, Toubiana, L, Van der Niepen, P, van Twist, D, Visonà, A, Wautrecht, Jc, Witowicz, H, Xu, J, Prejbisz, A, Januszewicz, A, Azizi, M, Persu, A, European/International FMD Registry and Initiative (FEIRI), and the Working Group ‘Hypertension and the Kidney’ of the European Society of Hypertension (ESH) Collaborators: Lucas, S Aparicio, Alexandre, Persu, Marco, Pappaccogli, Christophe, Beauloye, Patrick, Chenu, Frank, Hammer, Pierre, Goffette, Parla, Astarci, André, Peeters, Robert, Verhelst, Miikka, Vikkula, Patricia Van der Niepen, Frank Van Tussenbroek, Tine De Backer, Sofie, Gevaert, Dimitri, Hemelsoet, Luc, Defreyne, Hilde, Heuten, Laetitia, Yperzeele, Thijs Van der Zijden, Jean-Philippe, Lengelé, Jean-Marie, Krzesinski, Muriel, Sprynger, Philippe, Delmotte, Peter, Verhamme, Thomas, Vanassche, Pasquale, Scoppettuolo, Jean-Claude, Wautrecht, Wouter, Vinck, Vassilev, Dobrin, Yaneva, Teodora, Jiguang, Wang, Jianzhong, Xu, Bojan, Jelaković, Zivka, Dika, Daniel, Gordin, Ilkka, Tikkanen, Maarit, Venermo, N Mäkelä, R, Pierre-François, Plouin, Xavier, Jeunemaitre, Laurent, Toubiana, Michel, Azizi, Laurence, Amar, Antoine, Chédid, Elie, Mousseaux, Aurélien, Lorthioir, Olivier, Ormezzano, Christopher, Seinturier, Frédéric, Thony, Felix, Mahfoud, Saarraaken, Kulenthiran, Pantelis, Sarafidis, Alexia, Piperidou, Michael, Doumas, George, S Stergiou, Demetrios, Vlahakos, Caitriona, Canning, Yehonatan, Sharabi, Alberto, Morganti, Rosa Maria Bruno, Stefano, Taddei, Caterina, Romanini, Ilaria, Petrucci, Franco, Rabbia, Silvia Di Monaco, Gian Paolo Rossi, Silvia, Lerco, Minuz, Pietro, Mansueto, Giancarlo, DE MARCHI, Sergio, Marcon, Denise, Patrizia, Salice, Adriana, Visonà, Paola, Bigolin, Viviana, Zingaretti, Rosario, Cianci, Marialuisa, Zedde, Maria Chiara Matteucci, Yoshio, Iwashima, Osami, Kawarada, Yoshito, Kadoya, Daan, J van Twist, Bram, Kroon, Peter de Leeuw, Wilko, Spiering, Bert-Jan van den Born, Aud, Høieggen, Martin Skage Sommer, Andrzej, Januszewicz, Ewa, Warchoł-Celińska, Aleksander, Prejbisz, Adam, Witkowski, Helena, Witowicz, Jacek, Kądziela, Aleksandra, Soplińska, Krzysztof, Pieluszczak, Katarzyna, Jóżwik-Plebanek, Magdalena, Januszewicz, Elżbieta, Florczak, Piotr, Dobrowolski, Eva, Szabóová, Marek, Hudák, Matej, Moščovič, Juan Diego Mediavilla, Fernando Jaen Aguila, Anna, Oliveras, Julian, Segura, Jose, C Prado, Nicolas Roberto Robles, Esteban, Poch, Enrique, Montagud-Marrahi, Alicia, Molina, Elena, Guillen, Marta, Burrel, Patricia Fernàndez De la Llama, Antonio, J Barros-Membrilla, Anders, Gottsäter, Gregor, Wuerzner, Lucia, Mazzolai, Giacomo, Buso, Faiçal, Jarraya, Hanen, Chaker, David, Adlam, Constantina, Chrysochou, Neeraj, Dhaun, Robert, W Hunter, Iain, Macintyre, David, Webb, Public and occupational health, Vascular Medicine, ACS - Atherosclerosis & ischemic syndromes, APH - Personalized Medicine, APH - Global Health, ACS - Heart failure & arrhythmias, Interne Geneeskunde, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, RS: Carim - V02 Hypertension and target organ damage, MUMC+: MA Alg Interne Geneeskunde (9), Clinical sciences, Clinical Pharmacology and Clinical Pharmacy, Nephrology, CIC - HEGP (CIC 1418), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPC), UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - (SLuc) Service de pathologie cardiovasculaire, UCL - SSS/IREC/IMAG - Pôle d'imagerie médicale, UCL - SSS/IONS/NEUR - Clinical Neuroscience, UCL - SSS/DDUV/GEHU - Génétique, UCL - (SLuc) Service de radiologie, UCL - (SLuc) Service de neurologie, and UCL - (SLuc) Service de chirurgie cardiovasculaire et thoracique
- Subjects
Male ,renovascular hypertension ,Computed Tomography Angiography ,Physiology ,[SDV]Life Sciences [q-bio] ,Fibromuscular dysplasia ,030204 cardiovascular system & hematology ,Magnetic resonance angiography ,0302 clinical medicine ,Risk Factors ,Prevalence ,Registries ,Renovascular hypertension ,Stroke ,Computed tomography angiography ,medicine.diagnostic_test ,fibromuscular dysplasia ,dissection ,aneurysm ,stroke ,Incidence ,Dissection ,Age Factors ,Middle Aged ,Prognosis ,3. Good health ,Europe ,Phenotype ,Cohort ,cardiovascular system ,Female ,Cardiology and Cardiovascular Medicine ,circulatory and respiratory physiology ,Adult ,medicine.medical_specialty ,Asia ,Tunisia ,Aneurysm ,Argentina ,Risk Assessment ,03 medical and health sciences ,Sex Factors ,stomatognathic system ,Predictive Value of Tests ,Physiology (medical) ,Internal medicine ,medicine ,Humans ,cardiovascular diseases ,Aged ,business.industry ,medicine.disease ,Aortic Dissection ,Stenosis ,Angiography ,business ,Magnetic Resonance Angiography ,030217 neurology & neurosurgery - Abstract
AIMS: Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enrolled 1022 patients from 22 countries. We present their characteristics according to disease subtype, age and gender, as well as predictors of widespread disease, aneurysms and dissections. METHODS AND RESULTS: All patients diagnosed with FMD (string-of-beads or focal stenosis in at least one vascular bed) based on CTA, MRA and/or catheter-based angiography were eligible.Patients were predominantly women (82%) and Caucasians (88%). Age at diagnosis was 46±16 years (12% ≥65yo), 86% were hypertensive, 72% had multifocal and 57% multivessel FMD. Compared to patients with multifocal FMD, patients with focal FMD were younger, more often men, had less often multivessel FMD but more revascularizations. Compared to women with FMD, men were younger, had more often focal FMD and arterial dissections. Compared to younger patients with FMD, patients ≥65yo had more often multifocal FMD, lower eGFR and more atherosclerotic lesions. Independent predictors of multivessel FMD were age at FMD diagnosis, stroke, multifocal subtype, presence of aneurysm or dissection and family history of FMD. Predictors of aneurysms were multivessel and multifocal FMD. Predictors of dissections were age at FMD diagnosis, male gender, stroke and multivessel FMD. CONCLUSIONS: The European/International FMD Registry allowed large-scale characterization of distinct profiles of patients with FMD and, more importantly, identification of a unique set of independent predictors of widespread disease, aneurysms and dissections, paving the way for targeted screening, management and follow-up of FMD. TRANSLATIONAL PERSPECTIVE: Fibromuscular dysplasia (FMD) is nowadays considered as a systemic arterial disease, warranting brain-to-pelvis vascular imaging in all patients. However, most current evidence is derived from a limited number of expert centres. Furthermore, one size may not fit all. Based on analysis of the first thousand patients enrolled in the European/International FMD registry (46 centres; 22 countries) we characterized distinct patient profiles according to FMD subtype, age and gender and identified predictors of widespread disease, aneurysms and dissections, paving the way for individualized management and follow-up. Further studies will allow refining patient characterization according to ethnicity, genetic profile and imaging biomarkers.
- Published
- 2021
14. Intrarenal hemodynamics and kidney function in pheochromocytoma and paraganglioma before and after surgical treatment
- Author
-
Januszewicz, M., Dobrowolski, P., Januszewicz, A., Warchoł-Celińska, E., Jóźwik-Plebanek, K., Motyl, D., Kabat, M., Pęczkowska, M., Michałowska, I., Ambroziak, U., Toutounchi, S., Gałązka, Z., Courcelles, L., Pappaccogli, M., Eisenhofer, G., Persu, A., Lenders, J.W.M., Kądziela, J., Prejbisz, A., Januszewicz, M., Dobrowolski, P., Januszewicz, A., Warchoł-Celińska, E., Jóźwik-Plebanek, K., Motyl, D., Kabat, M., Pęczkowska, M., Michałowska, I., Ambroziak, U., Toutounchi, S., Gałązka, Z., Courcelles, L., Pappaccogli, M., Eisenhofer, G., Persu, A., Lenders, J.W.M., Kądziela, J., and Prejbisz, A.
- Abstract
Item does not contain fulltext, PURPOSE: Current evidence regarding renal involvement in pheochromocytoma and paraganglioma (PPGL) is scant. More accurate diagnostic methods, such as renal Doppler ultrasound for intrarenal hemodynamic studies, may provide more detailed information on renal function. It might be postulated that renal function in PPGL patients might be altered by high blood pressure and excess secretion of catecholamines. The aim of this prospective study was to assess intrarenal blood flow parameters in PPGL patients included in the prospective monoamine-producing tumour (PMT) study and to evaluate the effects of normalisation of catecholamine production after surgical treatment on long-term renal function. MATERIALS AND METHODS: Seventy consecutive patients (aged 46.5 ± 14.0 years) with PPGL were included. Forty-eight patients from the PMT study cohort, matched for age, gender, blood pressure level and presence of hypertension, served as a control group. Renal artery doppler ultrasound spectral analysis included mean resistance index (RRI) and pulsatility index (PI). Forty-seven patients completed 12 months follow-up. RESULTS: There were no differences in renal parameters such as RRI, PI and kidney function between PPGL and non-PPGL patients as assessed by renal ultrasound, serum creatinine, eGFR and albumin excretion rate. No correlations between kidney function parameters, intrarenal doppler flow parameters and plasma catecholamines were observed in PPGL patients. At 12 months after surgery, no differences in creatinine level, eGFR, albumin excretion rate, RI and PI were found as compared to baseline results. CONCLUSIONS: In contrast to patients with other forms of secondary hypertension, our study did not show differences in intrarenal blood flow parameters and renal function between PPGL and non-PPGL subjects. Intrarenal hemodynamics and renal function did not change after normalisation of catecholamine levels by surgical treatment.
- Published
- 2021
15. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic
- Author
-
Kreutz, R, Dobrowolski, P, Prejbisz, A, Algharably, E, Bilo, G, Creutzig, F, Grassi, G, Kotsis, V, Lovic, D, Lurbe, E, Modesti, P, Pappaccogli, M, Parati, G, Persu, A, Polonia, J, Rajzer, M, de Timary, P, Weber, T, Weisser, B, Tsioufis, K, Mancia, G, Januszewicz, A, Kreutz, Reinhold, Dobrowolski, Piotr, Prejbisz, Aleksander, Algharably, Engi A E-H, Bilo, Grzegorz, Creutzig, Felix, Grassi, Guido, Kotsis, Vasilios, Lovic, Dragan, Lurbe, Empar, Modesti, Pietro A, Pappaccogli, Marco, Parati, Gianfranco, Persu, Alexandre, Polonia, Jorge, Rajzer, Marek, de Timary, Philippe, Weber, Thomas, Weisser, Burkhard, Tsioufis, Konstantinos, Mancia, Giuseppe, Januszewicz, Andrzej, Kreutz, R, Dobrowolski, P, Prejbisz, A, Algharably, E, Bilo, G, Creutzig, F, Grassi, G, Kotsis, V, Lovic, D, Lurbe, E, Modesti, P, Pappaccogli, M, Parati, G, Persu, A, Polonia, J, Rajzer, M, de Timary, P, Weber, T, Weisser, B, Tsioufis, K, Mancia, G, Januszewicz, A, Kreutz, Reinhold, Dobrowolski, Piotr, Prejbisz, Aleksander, Algharably, Engi A E-H, Bilo, Grzegorz, Creutzig, Felix, Grassi, Guido, Kotsis, Vasilios, Lovic, Dragan, Lurbe, Empar, Modesti, Pietro A, Pappaccogli, Marco, Parati, Gianfranco, Persu, Alexandre, Polonia, Jorge, Rajzer, Marek, de Timary, Philippe, Weber, Thomas, Weisser, Burkhard, Tsioufis, Konstantinos, Mancia, Giuseppe, and Januszewicz, Andrzej
- Abstract
The coronavirus disease 2019 (COVID-19) pandemic considerably affects health, wellbeing, social, economic and other aspects of daily life. The impact of COVID-19 on blood pressure (BP) control and hypertension remains insufficiently explored. We therefore provide a comprehensive review of the potential changes in lifestyle factors and behaviours as well as environmental changes likely to influence BP control and cardiovascular risk during the pandemic. This includes the impact on physical activity, dietary patterns, alcohol consumption and the resulting consequences, for example increases in body weight. Other risk factors for increases in BP and cardiovascular risk such as smoking, emotional/psychologic stress, changes in sleep patterns and diurnal rhythms may also exhibit significant changes in addition to novel factors such as air pollution and environmental noise. We also highlight potential preventive measures to improve BP control because hypertension is the leading preventable risk factor for worldwide health during and beyond the COVID-19 pandemic.
- Published
- 2021
16. Enrichment of Rare Variants in Loeys-Dietz Syndrome Genes in Spontaneous Coronary Artery Dissection but Not in Severe Fibromuscular Dysplasia
- Author
-
Verstraeten, A, Perik, MHAM, Baranowska, AA, Meester, JAN, Van Den Heuvel, L, Bastianen, J, Kempers, M, Krapels, IPC, Maas, A, Rideout, A, Vandersteen, A, Sobey, G, JOHNSON, D, Fransen, E, Ghali, N, Webb, T, Al-Hussaini, A, de Leeuw, P, Delmotte, P, Lopez-Sublet, M, Pappaccogli, M, Sprynger, M, Toubiana, L, European/International Fibromuscular Dysplasia Registry and Initiative, (FEIRI), Van Laer, L, Van Dijk, FS, Vikkula, M, Samani, NJ, Persu, A, Adlam, D, Loeys, B, Collaborators of the European/International Fibromuscular Dysplasia Registry and Initiative, (FEIRI), Laboratoire d'Informatique Médicale et Ingénierie des Connaissances en e-Santé (LIMICS), and Université Paris 13 (UP13)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
fibromuscular dysplasia ,genetics ,[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM] ,Loeys-Dietz syndrome ,coronary artery disease - Published
- 2020
17. Pregnancy-related complications in patients with fibromuscular dysplasia: A report from the european/international fibromuscular dysplasia registry
- Author
-
Pappaccogli, M. Prejbisz, A. Ciuricǎ, S. Bruno, R.M. Aniszczuk-Hybiak, A. Bracalente, I. De Backer, T. Debiève, F. Delmotte, P. Di Monaco, S. Jarraya, F. Gordin, D. Kosiński, P. Kroon, A.A. Maas, A.H.E.M. Marcon, D. Minuz, P. Montagud-Marrahi, E. Pasquet, A. Poch, E. Rabbia, F. Stergiou, G.S. Tikkanen, I. Toubiana, L. Vinck, W. Warchoł-Celińska, E. Van Der Niepen, P. De Leeuw, P. Januszewicz, A. Persu, A.
- Subjects
cardiovascular system ,cardiovascular diseases - Abstract
Current literature suggests a higher risk of pregnancy-related complications in patients with renal fibromuscular dysplasia (FMD). The aim of our study was to assess the nature and prevalence of pregnancy-related complications in patients subsequently diagnosed with FMD. A call for participation was sent to centers contributing to the European/International FMD Registry. Patients with at least 1 pregnancy were included. Data on pregnancy were collected through medical files and FMD characteristics through the European/International FMD Registry. Data from 534 pregnancies were obtained in 237 patients. Despite the fact that, in 96% of cases, FMD was not diagnosed before pregnancy, 40% of women (n=93) experienced pregnancy-related complications, mostly gestational hypertension (25%) and preterm birth (20%), while preeclampsia was reported in only 7.5%. Only 1 patient experienced arterial dissection and another patient an aneurysm rupture. When compared with patients without pregnancy-related complications, patients with complicated pregnancies were younger at FMD diagnosis (43 versus 51 years old; P
- Published
- 2020
18. Enrichment of Rare Variants in Loeys-Dietz Syndrome Genes in Spontaneous Coronary Artery Dissection but Not in Severe Fibromuscular Dysplasia
- Author
-
Verstraeten, A., Perik, M., Baranowska, A.A., Meester, J.A., Heuvel, Lotte van den, Bastianen, J., Kempers, M.J.E., Krapels, I.P.C., Maas, A.H., Rideout, A., Vandersteen, A., Sobey, G., Johnson, D., Fransen, E., Ghali, N., Webb, T., Al-Hussaini, A., Leeuw, P. de, Delmotte, P., Lopez-Sublet, M., Pappaccogli, M., Sprynger, M., Toubiana, L., Laer, L. Van, Dijk, F.S. Van, Vikkula, M., Samani, N.J., Persu, A., Adlam, D., Loeys, B.L., Verstraeten, A., Perik, M., Baranowska, A.A., Meester, J.A., Heuvel, Lotte van den, Bastianen, J., Kempers, M.J.E., Krapels, I.P.C., Maas, A.H., Rideout, A., Vandersteen, A., Sobey, G., Johnson, D., Fransen, E., Ghali, N., Webb, T., Al-Hussaini, A., Leeuw, P. de, Delmotte, P., Lopez-Sublet, M., Pappaccogli, M., Sprynger, M., Toubiana, L., Laer, L. Van, Dijk, F.S. Van, Vikkula, M., Samani, N.J., Persu, A., Adlam, D., and Loeys, B.L.
- Abstract
Contains fulltext : 225439.pdf (Publisher’s version ) (Open Access)
- Published
- 2020
19. Pregnancy-Related Complications in Patients With Fibromuscular Dysplasia: A Report From the European/International Fibromuscular Dysplasia Registry
- Author
-
Pappaccogli, M., Prejbisz, A., Ciurică, S., Bruno, R.M., Aniszczuk-Hybiak, A., Bracalente, I., Backer, T. De, Debiève, F., Delmotte, P., Monaco, S., Jarraya, F., Gordin, D., Kosiński, P., Kroon, A.A., Maas, A.H.E.M., Marcon, D., Minuz, P., Montagud-Marrahi, E., Pasquet, A., Poch, E., Rabbia, F., Stergiou, G.S., Tikkanen, I., Toubiana, L., Vinck, W., Warchoł-Celińska, E., Niepen, P. Van der, Leeuw, P. de, Januszewicz, A., Persu, A., Pappaccogli, M., Prejbisz, A., Ciurică, S., Bruno, R.M., Aniszczuk-Hybiak, A., Bracalente, I., Backer, T. De, Debiève, F., Delmotte, P., Monaco, S., Jarraya, F., Gordin, D., Kosiński, P., Kroon, A.A., Maas, A.H.E.M., Marcon, D., Minuz, P., Montagud-Marrahi, E., Pasquet, A., Poch, E., Rabbia, F., Stergiou, G.S., Tikkanen, I., Toubiana, L., Vinck, W., Warchoł-Celińska, E., Niepen, P. Van der, Leeuw, P. de, Januszewicz, A., and Persu, A.
- Abstract
Contains fulltext : 225490.pdf (Publisher’s version ) (Closed access), Current literature suggests a higher risk of pregnancy-related complications in patients with renal fibromuscular dysplasia (FMD). The aim of our study was to assess the nature and prevalence of pregnancy-related complications in patients subsequently diagnosed with FMD. A call for participation was sent to centers contributing to the European/International FMD Registry. Patients with at least 1 pregnancy were included. Data on pregnancy were collected through medical files and FMD characteristics through the European/International FMD Registry. Data from 534 pregnancies were obtained in 237 patients. Despite the fact that, in 96% of cases, FMD was not diagnosed before pregnancy, 40% of women (n=93) experienced pregnancy-related complications, mostly gestational hypertension (25%) and preterm birth (20%), while preeclampsia was reported in only 7.5%. Only 1 patient experienced arterial dissection and another patient an aneurysm rupture. When compared with patients without pregnancy-related complications, patients with complicated pregnancies were younger at FMD diagnosis (43 versus 51 years old; P<0.001) and had a lower prevalence of cerebrovascular FMD (30% versus 52%; P=0.003) but underwent more often renal revascularization (63% versus 40%, P<0.001). In conclusion, the prevalence of pregnancy-related complications such as gestational hypertension and preterm birth was high in patients with FMD, probably related to the severity of renal FMD. However, the prevalence of preeclampsia and arterial complications was low/moderate. These findings emphasize the need to screen hypertensive women for FMD to ensure revascularization before pregnancy if indicated and appropriate follow-up during pregnancy, without discouraging patients with FMD from considering pregnancy.
- Published
- 2020
20. A description of Physical Therapists Knowledge in Basic Competence Examination of Musculo-skeletal Conditions an Italian National Cross-Sectional Survey
- Author
-
Giovannico, G., primary, Brindisino, F., additional, Pappaccogli, M., additional, Saltalamacchia, A., additional, Bonetti, F., additional, Tavarnelli, M., additional, Mezzetti, M., additional, and Delitto, A., additional
- Published
- 2020
- Full Text
- View/download PDF
21. Coronary arteries in fibromuscular dysplasia. 3-Dimensional coronary CT, case-control study. The ARCARDIA-POL BIS study
- Author
-
Kruk, M, primary, Szkamruk, K, additional, Adlam, D, additional, Persu, A, additional, Pappaccogli, M, additional, Van Der Niepen, P, additional, Kepka, C, additional, Januszewicz, M, additional, Pregowski, J, additional, Skowronski, J, additional, Kabat, M, additional, Warchol-Celinska, E, additional, Prejbisz, A, additional, Dobrowolski, P, additional, and Januszewicz, A, additional
- Published
- 2020
- Full Text
- View/download PDF
22. Aortic invovement in fibromuscular dysplasia. 3-dimensional CT, case-control study. THE ARCADIA-POL BIS study
- Author
-
Szkamruk, K, primary, Kruk, M, additional, Kepka, C, additional, Adlam, D, additional, Persu, A, additional, Canning, C, additional, Pappaccogli, M, additional, Van Der Niepen, P, additional, Januszewicz, M, additional, Kabat, M, additional, Warchol-Celinska, E, additional, Prejbisz, A, additional, Jozwik-Plebanek, K, additional, Dobrowolski, P, additional, and Januszewicz, A, additional
- Published
- 2020
- Full Text
- View/download PDF
23. THE EUROPEAN/INTERNATIONAL FIBROMUSCULAR DYSPLASIA REGISTRY: MAIN FINDINGS IN THE FIRST THOUSAND PATIENTS
- Author
-
Pappaccogli, M., Di Monaco, S., Aparicio, L. S., Azizi, M., Bruno, R. M., De Leeuw, P. W., Delmotte, P., Gordin, D., Iwashima, Y., Januszewicz, A., Kroon, A. A., Lorthioir, A., Poch, E., Prejbisz, A., Seinturier, C., Toubiana, L., Van Der Niepen, P., Wang, J., Wautrecht, J. Claude, Persu, A., Clinical sciences, Clinical Pharmacology and Clinical Pharmacy, Nephrology, and Faculty of Economic and Social Sciences and Solvay Business School
- Published
- 2019
24. DISTINCTIVE FEATURES OF PATIENTS DIAGNOSED WITH FIBROMUSCULAR DYSPLASIA (FMD) AT AN OLDER AGE: A REPORT FROM THE EUROPEAN/INTERNATIONAL FMD REGISTRY
- Author
-
Pappaccogli, M., Di Monaco, S., Amar, L., Aparicio, L. S., Azizi, M., Bruno, R. M., De Leeuw, P. W., Delmotte, P., Iwashima, Y., Januszewicz, A., Kroon, A. A., Poch, E., Prejbisz, A., Seinturier, C., Tikkanen, I., Toubiana, L., Van Der Niepen, P., Scoppettuolo, P., Persu, Al., Clinical sciences, Clinical Pharmacology and Clinical Pharmacy, and Nephrology
- Published
- 2019
25. Patologie da sovraccarico di ferro
- Author
-
Crea, B, Cavaglia', G, Mingrone, G, Pappaccogli, M, Tetti, M, Valente, M, Roetto, A, and De Gobbi, M
- Published
- 2019
26. Predictors of blood pressure control in patients with resistant hypertension after intensive management in two expert centres: the Brussels-Torino experience.
- Author
-
UCL - SSH/IACS - Institute of Analysis of Change in Contemporary and Historical Societies, Pappaccogli M., Di Monaco S., Coralie G., Petit, Géraldine, Eula E., Ritscher S., Lengelé JP, Fanelli E, Severino F, Renkin J, Avataneo V, Wallemacq P, Toennes SW, de Timary P, Rabbia F, Persu A, UCL - SSH/IACS - Institute of Analysis of Change in Contemporary and Historical Societies, Pappaccogli M., Di Monaco S., Coralie G., Petit, Géraldine, Eula E., Ritscher S., Lengelé JP, Fanelli E, Severino F, Renkin J, Avataneo V, Wallemacq P, Toennes SW, de Timary P, Rabbia F, and Persu A
- Published
- 2019
27. CARDIOVASCULAR CHANGES DUE TO PHYSICAL ACTIVITY IN OBESE AND/OR HYPERTENSIVE CHILDREN
- Author
-
Eula, E., primary, Abate Daga, F., additional, Fulcheri, C., additional, Di Monaco, S., additional, Pappaccogli, M., additional, Perlo, E., additional, Fanelli, E., additional, Fasano, C., additional, Totaro, S., additional, Rabbone, I., additional, Gollin, M., additional, Rabbia, F., additional, and Veglio, F., additional
- Published
- 2019
- Full Text
- View/download PDF
28. EFFECT OF DIFFERENT BLOOD PRESSURE TARGETS AND MEASUREMENT METHODS ON PREVALENCE OF CONTROLLED HYPERTENSION
- Author
-
Pappaccogli, M., primary, Rabbia, F., additional, Di Monaco, S., additional, Perlo, E., additional, Maldarizzi, C., additional, Fulcheri, C., additional, Milan, A., additional, Mulatero, P., additional, and Veglio, F., additional
- Published
- 2018
- Full Text
- View/download PDF
29. NURSE-OBP
- Author
-
Pappaccogli, M., primary, Rabbia, F., additional, Di Monaco, S., additional, Perlo, E., additional, Maldarizzi, C., additional, Eula, E., additional, Fulcheri, C., additional, Milan, A., additional, Mulatero, P., additional, and Veglio, F., additional
- Published
- 2018
- Full Text
- View/download PDF
30. [PP.25.08] THERAPEUTIC DRUG MONITORING IN RESISTANT HYPERTENSIVES PREVIOUSLY TREATED WITH INVASIVE APPROACHES
- Author
-
Rabbia, F., primary, Fulcheri, C., additional, Perlo, E., additional, Avataneo, V., additional, De Nicolo’, A., additional, Berra, E., additional, Pappaccogli, M., additional, Di Monaco, S., additional, Rossato, D., additional, D’avolio, A., additional, and Veglio, F., additional
- Published
- 2017
- Full Text
- View/download PDF
31. [PP.26.01] SLEEPING QUALITY AND AMBULATORY BLOOD PRESSURE MONITORING PROFILE
- Author
-
Di Monaco, S., primary, Rabbia, F., additional, Berra, E., additional, Covella, M., additional, Fulcheri, C., additional, Pappaccogli, M., additional, Perlo, E., additional, Maldarizzi, C., additional, and Veglio, F., additional
- Published
- 2017
- Full Text
- View/download PDF
32. [BP.10.07] EFFECTIVENESS OF RENAL DENERVATION IN RESISTANT HYPERTENSION
- Author
-
Pappaccogli, M., primary, Covella, M., additional, Rabbia, F., additional, Berra, E., additional, Fulcheri, C., additional, Di Monaco, S., additional, Perlo, E., additional, Maldarizzi, C., additional, and Veglio, F., additional
- Published
- 2017
- Full Text
- View/download PDF
33. [PP.01.15] ACCURACY OF HOME BLOOD PRESSURE MONITORING IN ARTERIAL HYPERTENSION DIAGNOSIS
- Author
-
Di Monaco, S., primary, Rabbia, F., additional, Covella, M., additional, Bertello, C., additional, Papotti, G., additional, Fulcheri, C., additional, Berra, E., additional, Pappaccogli, M., additional, Perlo, E., additional, and Veglio, F., additional
- Published
- 2016
- Full Text
- View/download PDF
34. [PP.23.13] ANALYSIS OF ELIGIBILITY CRITERIA FOR RENAL SYMPATHETIC DENERVATION
- Author
-
Fulcheri, C., primary, Rabbia, F., additional, Testa, E., additional, Berra, E., additional, Di Monaco, S., additional, Covella, M., additional, Pappaccogli, M., additional, Perlo, E., additional, and Veglio, F., additional
- Published
- 2016
- Full Text
- View/download PDF
35. PP.31.04
- Author
-
Di Monaco, S., primary, Rabbia, F., additional, Covella, M., additional, Frualdo, M., additional, Fulcheri, C., additional, Totaro, S., additional, Testa, E., additional, Berra, E., additional, Pappaccogli, M., additional, Perlo, E., additional, and Veglio, F., additional
- Published
- 2015
- Full Text
- View/download PDF
36. A description of Physical Therapists' Knowledge in Basic Competence Examination of Musculoskeletal Conditions: an Italian National Cross-Sectional Survey.
- Author
-
Giovannico, G., Brindisino, F., Pappaccogli, M., Saltalamacchia, A., Bonetti, F., Tavarnelli, M., Mezzetti, M., and Delitto, A.
- Subjects
- *
ACADEMIC achievement , *MANIPULATION therapy , *MUSCULOSKELETAL system diseases , *PRIMARY health care , *PROFESSIONS , *SURVEYS , *JOB performance , *PROFESSIONAL licensure examinations , *CROSS-sectional method , *PHYSICAL therapy students , *DESCRIPTIVE statistics , *INFERENTIAL statistics - Abstract
Background. According to the World Health Organization, musculoskeletal conditions (MSC) are a major contributor of disability worldwide. The prevalence and impact of MSC has created the need for more careful reflection on how all health professionals are trained about the appropriateness and cost-effectiveness of treatments for these complaints. Aim. To evaluate basic musculoskeletal knowledge in a population of Italian students and physiotherapists. Methods. Adaptation in Italian context and administration of 25-items quantitative cross-sectional paper-based survey was conducted. 460 physiotherapy students and graduates were involved in the survey. The survey focuses on the most common diagnoses seen in the musculoskeletal field and in the context of primary care. Data was analyzed by descriptive and inferential statistics. Results. Four-hundred and sixty respondents completed this paper-based survey. Overall respondents' average score was 45.03/100 (pass rate of 7.8%). Physiotherapists with degrees (n=318) obtained an average score of 49.28/100 (SD +/- 18.08), with an overall pass rate of 10.7%. Physiotherapists with degrees and specialized in Manual Therapy obtained higher scores than non-specialized colleagues (62.40/100, SD +/- 16.63 and 39.83/100, SD +/- 15.90, respectively). Moreover, physiotherapists specialized in Manual Therapy obtained a significantly different sufficiency pass rate and did better than their non-specialized colleagues (28.3% versus 1.7%, p < 0.01) and even better than their colleagues specialized in Sports physiotherapy (average score 52.89/100, SD +/- 17.50, pass rate 11.1%). Physiotherapists with a Master of Science averaged a score of 61.37/100 (SD +/- 17.94) and a pass rate of 37.5%. Second year physiotherapy students scored 15.83/100 (SD +/- 10.57), while third year students scored 39.53/100 (SD +/- 14.26); however, students achieved a very low pass rate (0% and 1.7% respectively for the 2nd and the 3rd year students). Discussion and conclusions. This study provokes deep reflection on the structure and contents of the physiotherapy degree course: the results of this survey could lead to a radical restructuring of the academic syllabus so as to allow this scientific discipline to reach its full potential. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
37. Management of Renovascular Hypertension and Renal Denervation in Patients with Hypertension: An Italian Nationwide Survey.
- Author
-
Pappaccogli M, Ponsa L, Goi J, Burrello J, Di Dalmazi G, Cicero AFG, Mancusi C, Moia EC, Iaccarino G, Borghi C, Muiesan ML, Ferri C, Rabbia F, and Mulatero P
- Subjects
- Humans, Italy epidemiology, Treatment Outcome, Prevalence, Female, Male, Middle Aged, Adult, Hypertension, Renovascular diagnosis, Hypertension, Renovascular surgery, Hypertension, Renovascular epidemiology, Hypertension, Renovascular physiopathology, Hypertension, Renovascular therapy, Practice Patterns, Physicians' trends, Health Care Surveys, Renal Artery innervation, Renal Artery surgery, Sympathectomy adverse effects, Blood Pressure, Kidney innervation
- Abstract
Introduction: Renovascular hypertension (RVH) remains underdiagnosed despite its significant cardiovascular and renal morbidity., Aim: This survey investigated screening and management practices for RVH among hypertensive patients in Italian hypertension centres in a real-life setting. Secondary, we analysed the current spread of renal denervation (RDN) and the criteria used for its eligibility., Methods: A 12 item-questionnaire was sent to hypertension centres belonging to the European Society of Hypertension and to the Italian Society of Hypertension (SIIA) in Italy. Data concerning the screening and management of RVH and of RDN were analysed according to the type of centre (excellence vs non-excellence centres), geographical area and medical specialty., Results: Eighty-two centres participated to the survey. The number of patients diagnosed in each centre with RVH and fibromuscular dysplasia during the last five years was 3 [1;6] and 1 [0;2], respectively. Despite higher rates of RVH diagnosis in excellence centres (p = 0.017), overall numbers remained unacceptably low, when compared to expected prevalence estimates. Screening rates were inadequate, particularly among young hypertensive patients, with only 28% of the centres screening for RVH in such population. Renal duplex ultrasound was underused, with computed tomographic angiography or magnetic resonance angiography reserved for confirming a RVH diagnosis (76.8%) rather than for screening (1.9-32.7%, according to patients' characteristics). Scepticism and logistical challenges limited RDN widespread adoption., Conclusions: These findings underscore the need for improving RVH screening strategies and for a wider use of related diagnostic tools. Enhanced awareness and adherence to guidelines are crucial to identifying renovascular hypertension and mitigating associated cardiovascular and renal risks., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
38. Multiple drug intolerance in antihypertensive patients: what is known and what is missing.
- Author
-
Palermiti A, Pappaccogli M, Rabbia F, D'Avolio A, and Veglio F
- Subjects
- Humans, Drug Hypersensitivity, Hypertension drug therapy, Antihypertensive Agents therapeutic use, Antihypertensive Agents adverse effects
- Abstract
Drug allergy and intolerance are increasingly recognized as significant public health concerns, leading to adverse reactions in patients undergoing pharmacological treatments. Multiple drug intolerance syndrome (MDIS), characterized by adverse reactions to at least three different drug classes without a clear immunological mechanism, poses a substantial challenge, particularly in hypertensive patients. Despite its link to suboptimal adherence and uncontrolled blood pressure, MDIS in the context of hypertension remains insufficiently explored. This review synthesizes existing literature on MDIS, emphasizing clinical characteristics, pathogenesis, and psychiatric comorbidity. Furthermore, it delves into MDIS in the context of hypertension, highlighting the importance of a multidisciplinary approach in diagnosis and management, including innovative therapeutic strategies such as novel therapeutic algorithms or renal denervation. The review concludes by emphasizing the necessity for further research and clinical trials to enhance our understanding and address MDIS, especially in hypertensive patients., (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
39. The Musculoskeletal 30-question multiple choice questionnaire (MSK-30): a new assessing tool of musculoskeletal competence in a sample of Italian physiotherapists.
- Author
-
Giovannico G, Pappaccogli M, Cioeta M, Pellicciari L, Youssef S, Angilecchia D, Giannotta G, and Brindisino F
- Subjects
- Humans, Physical Examination, Educational Status, Surveys and Questionnaires, Physical Therapists, Musculoskeletal Diseases diagnosis, Musculoskeletal Diseases epidemiology, Musculoskeletal Diseases therapy
- Abstract
Background: The prevalence and cost of musculoskeletal diseases increased dramatically over the past few decades. Therefore, several institutions have begun to re-evaluate the quality of their musculoskeletal educational paths. However, current standardized questionnaires inadequately assess musculoskeletal knowledge, and other musculoskeletal-specific exams have limitations in implementation. The musculoskeletal 30-question multiple choice questionnaire (MSK-30) was proposed as a new tool for assessing basic musculoskeletal knowledge., Aim: To analyse basic musculoskeletal knowledge in a sample of Italian physiotherapists by administering the MSK-30 questionnaire., Methods: After a transcultural adaptation process, the MSK-30 was developed and administered to Italian physiotherapists to assess their musculoskeletal knowledge. Participants were invited to participate in the survey via the SurveyMonkey link. Mann-Whitney test and the Kruskal-Wallis test with Bonferroni correction were used to observe the differences between groups in the MSK-30 scores., Results: Four hundred-fourteen (n=414) physiotherapists participated in the survey. The median MSK-30 value was higher in physiotherapists who attended the International Federation of Orthopaedic Manipulative Physical Therapists postgraduate certification than in those who attended unstructured postgraduate training in musculoskeletal condition or in those who had not completed any postgraduate training in this field (p<0.001)., Conclusions: This work demonstrates significant differences in the management of musculoskeletal disorders between those with specific postgraduate university education and those without. The findings can contribute to the advancement of the physiotherapy profession in Italy. Authors recommend further research with more robust methodologies to deeper understand this topic. Musculoskeletal conditions will continue to represent a significant portion of primary care visits, and future generations of physiotherapists must be prepared to address this challenge., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
40. Risks and benefits of renal artery stenting in fibromuscular dysplasia: Lessons from the ARCADIA-POL study.
- Author
-
Kądziela J, Jóźwik-Plebanek K, Pappaccogli M, van der Niepen P, Prejbisz A, Dobrowolski P, Michałowska I, Talarowska P, Warchoł-Celińska E, Stryczyński Ł, Krekora J, Andziak P, Szczerbo-Trojanowska M, Maciąg R, Sterliński I, Witkowski A, Januszewicz A, Adlam D, Januszewicz M, and Persu A
- Subjects
- Humans, Renal Artery diagnostic imaging, Renal Artery surgery, Retrospective Studies, Treatment Outcome, Risk Assessment, Stents adverse effects, Fibromuscular Dysplasia complications, Fibromuscular Dysplasia diagnostic imaging, Fibromuscular Dysplasia therapy, Angioplasty, Balloon adverse effects, Renal Artery Obstruction diagnostic imaging, Renal Artery Obstruction etiology, Renal Artery Obstruction therapy
- Abstract
Introduction: Although renal stenting is the standard revascularization method for atherosclerotic renal artery stenosis (RAS) (FMD-RAS), stenting in fibromuscular dysplasia (FMD) RAS is usually limited to periprocedural complications of angioplasty and primary arterial dissection. The main aim of the study was to retrospectively analyze the immediate and long-term results of renal stenting versus angioplasty in patients with FMD., Methods: Of 343 patients in the ARCADIA-POL registry, 58 patients underwent percutaneous treatment due to FMD-RAS (in 70 arteries). Percutaneous transluminal renal angioplasty (PTRA) was performed as an initial treatment in 61 arteries (PTRA-group), whereas primary stenting was undertaken in nine arteries (stent-group). Stent-related complications were defined as: in-stent restenosis > 50% (ISR); stent fracture; under-expansion; or migration., Results: In the PTRA-group, the initial restenosis rate was 50.8%. A second procedure was then performed in 22 arteries: re-PTRA (12 arteries) or stenting (10 arteries). The incidence of recurrent restenosis after re-PTRA was 41.7%. Complications occurred in seven of 10 (70%) arteries secondarily treated by stenting: two with under-expansion and five with ISR. In the stent-group, stent under-expansion occurred in one case (11.1%) and ISR in three of nine stents (33.3%). In combined analysis of stented arteries, either primarily or secondarily, stent-related complications occurred in 11/19 stenting procedures (57.9%): three due to under-expansion and eight due to ISRs. Finally, despite several revascularization attempts, four of 19 (21%) stented arteries were totally occluded and one was significantly stenosed at follow-up imaging., Conclusion: Our study indicates that renal stenting in FMD-RAS may carry a high risk of late complications, including stent occlusion. Further observational data from large-scale registries are required., Competing Interests: Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
41. Endovascular Versus Medical Management of Atherosclerotic Renovascular Disease: Update and Emerging Concepts.
- Author
-
Pappaccogli M, Robberechts T, Lengelé JP, Van der Niepen P, Sarafidis P, Rabbia F, and Persu A
- Subjects
- Humans, Retrospective Studies, Atherosclerosis diagnosis, Atherosclerosis therapy, Hypertension, Renovascular diagnosis, Hypertension, Renovascular etiology, Hypertension, Renovascular therapy, Renal Artery Obstruction diagnosis, Renal Artery Obstruction therapy, Kidney Failure, Chronic diagnosis
- Abstract
Atherosclerotic renovascular disease is the most frequent cause of renovascular hypertension and its prevalence increases with age and in specific subset of patients, such as those with end-stage chronic kidney disease, heart failure, and coronary artery disease. Besides hypertension, atherosclerotic renovascular disease is responsible for several clinical manifestations, including life-threatening conditions, such as recurrent flash pulmonary edema, rapidly progressive chronic kidney disease, or acute kidney injury. Atherosclerotic renovascular disease is usually part of a more diffuse atherosclerotic process and requires a combination therapy including antihypertensive, antiplatelet and lipid-lowering agents, as well as optimization of antidiabetic treatment, if needed. Besides medical therapy, percutaneous renal angioplasty was supposed to be the most effective therapy for atherosclerotic renovascular disease, by leading to blood flow restoration. However, despite an apparently solid rationale, several randomized clinical trials failed to confirm the favorable effects of percutaneous renal angioplasty on blood pressure control, kidney function, cardiovascular and renal outcomes, previously reported in observational, retrospective and single-center cohorts, switching off the enthusiasm for this procedure. Several studies' limitations may partly account for this failure, including heterogeneity of diagnostic techniques, overestimation of the degree of renal artery stenosis, inappropriate timing of revascularization, multiple protocol revisions, frequent crossovers, and most importantly exclusion of patients at higher likelihood to respond to angioplasty. The purpose of this review is to summarize studies' potential weaknesses and provide guidance to the clinician for identification of patients who may benefit most from revascularization., Competing Interests: Disclosures None.
- Published
- 2023
- Full Text
- View/download PDF
42. Psychological determinants of drug adherence and severity of hypertension in patients with apparently treatment-resistant vs. controlled hypertension.
- Author
-
Georges CMG, Ritscher S, Pappaccogli M, Petit G, Lopez-Sublet M, Bapolisi A, Di Monaco S, Wallemacq P, Rabbia F, Toennes SW, de Timary P, and Persu A
- Subjects
- Blood Pressure, Blood Pressure Monitoring, Ambulatory, Humans, Medication Adherence, Pilot Projects, Antihypertensive Agents pharmacology, Antihypertensive Agents therapeutic use, Hypertension
- Abstract
Purpose: In a pilot study including 35 patients with apparently treatment-resistant hypertension (ATRH), we documented associations between psychological profile, drug adherence and severity of hypertension. The current study aims to confirm and expand our findings in a larger and more representative sample of patients with ATRH, using controlled hypertensive patients as the comparator., Materials and Methods: Patients with ATRH were enrolled in hypertension centres from Brussels and Torino. The psychological profile was assessed using five validated questionnaires. Drug adherence was assessed by high-performance liquid chromatography-tandem mass spectrometry analysis of urine samples, and drug resistance by 24-hour ambulatory blood pressure was adjusted for drug adherence., Results: The study sample totalised 144 patients, including 81 ATRH and 63 controlled hypertensive patients. The mean adherence level was significantly lower in the "resistant" group (78.9% versus 92.7% in controlled patients, p -value = .022). In patients with ATRH, independent predictors of poor drug adherence were somatisation, smoking and low acceptance level of difficult situations, accounting for 41% of the variability in drug adherence. Independent predictors of severity of hypertension were somatisation, smoking, more frequent admissions to the emergency department and low acceptation, accounting for 63% of the variability in the severity of hypertension. In contrast, in patients with controlled hypertension, the single predictors of either drug adherence or severity of hypertension were the number of years of hypertension and, for the severity of hypertension, alcohol consumption, accounting for only 15-20% of the variability., Conclusion: Psychological factors, mostly related to somatisation and expression of emotions are strong, independent predictors of both drug adherence and severity of hypertension in ATRH but not in controlled hypertensive patients.
- Published
- 2022
- Full Text
- View/download PDF
43. Drug adherence and psychological factors in patients with apparently treatment-resistant hypertension: Yes but which ones?
- Author
-
Georges CMG, Pappaccogli M, Fanelli E, Petit G, Ritscher S, Lopez-Sublet M, Bapolisi A, Wallemacq P, Rabbia F, de Timary P, Toennes SW, and Persu A
- Subjects
- Humans, Male, Middle Aged, Blood Pressure Monitoring, Ambulatory, Antihypertensive Agents pharmacology, Medication Adherence, Chromatography, Liquid methods, Blood Pressure, Hypertension drug therapy, Hypertension epidemiology, Hypertension diagnosis
- Abstract
The aim of the study was to assess drug adherence, as well as association of psychological factors with both drug adherence and severity of hypertension in two subtypes of patients with apparently treatment-resistant hypertension (ATRH): younger patients with uncomplicated hypertension (YURHTN) versus patients ≥60-year-old and/or with a history of cardio- or cerebrovascular complication (OCRHTN). Drug adherence was assessed in urine by targeted Liquid Chromatography-Mass Spectrometry. The severity of hypertension was assessed by 24-h ambulatory blood pressure adjusted for the number of antihypertensive drugs and for drug adherence. Psychological profile was assessed using five validated questionnaires. The proportion of totally non-adherent patients was three times higher (24.1 vs. 7.1%, P = 0.026) in the YURHTN (n = 54) than in OCRHTN subgroup (n = 43). Independent predictors of drug adherence in YURHTN were ability to use adaptive strategies, male sex and family history of hypertension, accounting for 39% of variability in drug adherence. In the same subgroup, independent predictors of severity of hypertension were somatization and lower recourse to planification, accounting for 40% of variability in the severity of hypertension. In contrast, in the OCRHTN subgroup, independent predictors of drug adherence and severity of hypertension were limited to the number of yearly admissions to the emergency room and the total number of prescribed drugs. In conclusion, poor drug adherence and altered psychological profiles appear to play a major role in younger patients with ATRH devoid of cardiovascular complication. This subgroup should be prioritized for chemical detection of drug adherence and psychological evaluation., (© 2022 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
44. Comparison of nurse attended and unattended automated office blood pressure with conventional measurement techniques in clinical practice.
- Author
-
Fanelli E, Di Monaco S, Pappaccogli M, Eula E, Fasano C, Bertello C, Veglio F, and Rabbia F
- Subjects
- Blood Pressure, Blood Pressure Monitoring, Ambulatory, Humans, Blood Pressure Determination methods, Hypertension diagnosis
- Abstract
Accuracy in blood pressure measurement is critical for proper hypertension diagnosis and treatment in clinical practice. Automated office blood pressure (AOBP) can simplify the measurement process, reducing human error and minimizing the white-coat effect in the unattended mode. The aim of this study was to compare AOBP, both unattended and nurse attended, with conventional office and out-of-office blood pressure measurement techniques. Four different methods of blood pressure measurement were performed in a cohort of hypertensive patients: conventional office blood pressure (OBP), unattended automated office blood pressure (uAOBP), nurse attended automated office blood pressure (nAOBP), and home blood pressure monitoring (HBPM). uAOBP and nAOBP were conducted with the same rigorous standardized procedure. We enrolled 118 consecutive patients. nAOBP values were slightly higher than uAOBP ones (respectively 132.8/73.3 ± 19.4/12.9 and 129.2/71.1 ± 19.0/12.3 mmHg), even if the difference was influenced by order of execution of AOBP measurement. nAOBP was significantly lower than HBPM and OBP (mean values 135.2/80.9 ± 16.6/8.1 and 140.9/84.6 ± 18.7/10.8 mmHg, respectively). AOBP, either attended or unattended, provides lower values than conventional OBP. uAOBP and nAOBP values showed small differences, even if they are not completely interchangeable. This evidence reflects a lower white-coat effect, even in nurse attended technique, but is also due to a lower measurement error through the application of a rigorous standardized protocol., (© 2021. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2022
- Full Text
- View/download PDF
45. Author Correction: Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases.
- Author
-
Georges A, Yang ML, Berrandou TE, Bakker MK, Dikilitas O, Kiando SR, Ma L, Satterfield BA, Sengupta S, Yu M, Deleuze JF, Dupré D, Hunker KL, Kyryachenko S, Liu L, Sayoud-Sadeg I, Amar L, Brummett CM, Coleman DM, d'Escamard V, de Leeuw P, Fendrikova-Mahlay N, Kadian-Dodov D, Li JZ, Lorthioir A, Pappaccogli M, Prejbisz A, Smigielski W, Stanley JC, Zawistowski M, Zhou X, Zöllner S, Amouyel P, De Buyzere ML, Debette S, Dobrowolski P, Drygas W, Gornik HL, Olin JW, Piwonski J, Rietzschel ER, Ruigrok YM, Vikkula M, Warchol Celinska E, Januszewicz A, Kullo IJ, Azizi M, Jeunemaitre X, Persu A, Kovacic JC, Ganesh SK, and Bouatia-Naji N
- Published
- 2022
- Full Text
- View/download PDF
46. Association between post-traumatic stress disorder and hypertension in Congolese exposed to violence: a case-control study.
- Author
-
Bapolisi A, Maurage P, Pappaccogli M, Georges CMG, Petit G, Balola M, Cikomola C, Bisimwa G, Burnier M, Persu A, and de Timary P
- Subjects
- Adult, Case-Control Studies, Female, Humans, Male, Middle Aged, Violence, Depressive Disorder, Major psychology, Hypertension epidemiology, Stress Disorders, Post-Traumatic diagnosis
- Abstract
Background: Numerous risk factors have been involved in the pathogenesis of hypertension. The contribution of psychological factors, including post-traumatic stress disorder, remains largely underexplored, despite their potential role in hypertension., Objectives: We compared the prevalence of trauma, post-traumatic stress and other psychological disorders between hypertensive and normotensive patients from Bukavu (Democratic Republic of Congo), a 25-year war-exposed city., Methods and Measures: In this case-control study, we assessed past traumatic events with the Stressful-Events-Scale, post-traumatic stress disorder through the post-traumatic diagnostic scale, depression and alcohol use disorder through the MINI-International-Neuropsychiatric-Interview, and emotion regulation through the Emotion-Regulation-Questionnaire in 106 hypertensive and 106 normotensive patients, enrolled at the Bukavu General Hospital., Results: Compared with normotensive controls (73% women, age: 43 ± 14 years, BP: 121 ± 10/75 ± 8 mmHg), hypertensive patients (57% women, age: 42 ± 13 years, BP: 141 ± 12/82 ± 7 mmHg, on a median of two antihypertensive drugs) were exposed to more man-made traumas (61 vs. 13%, P < 0.001), used more expressive suppression (P = 0.05) and less cognitive reappraisal (P = 0.02) as emotional regulation strategies. They developed more frequent post-traumatic stress disorder (36 vs. 7%, P < 0.001) and major depressive disorder (37 vs. 13%, P = 0.001), often in association with alcohol use disorder (23 vs. 4%, P < 0.001). In multivariate logistic regression, post-traumatic stress disorder [OR = 3.52 (1.23-6.54)], man-made trauma [OR = 2.24 (1.15-4.12)], family history of hypertension [OR = 2.24 (1.06-4.44)], fasting blood glucose [OR = 1.85 (1.07-3.08)], BMI [OR = 1.28 (1.12-2.92)], expressive suppression [OR = 1.23 (1.11-2.23)] and cognitive reappraisal [OR = 0.76 (0.63-0.98)] were independent predictors of hypertension., Conclusion: In Congolese populations exposed to war, man-made trauma exposure and post-traumatic stress disorder appear to be more tightly related to hypertension than classical hypertension risk factors., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
47. A structured physical activity program in an adolescent population with overweight or obesity: a prospective interventional study.
- Author
-
Fanelli E, Abate Daga F, Pappaccogli M, Eula E, Astarita A, Mingrone G, Fasano C, Magnino C, Schiavone D, Rabbone I, Gollin M, Rabbia F, and Veglio F
- Subjects
- Adolescent, Body Mass Index, Exercise, Humans, Obesity therapy, Prospective Studies, Overweight, Pulse Wave Analysis
- Abstract
Obesity is a significant health problem, with increasing involvement of young population worldwide. The aim of this study was to evaluate the effects of 2 different types of physical exercise (resistance vs. combined aerobic-resistance) on cardiovascular and anthropometric profile of a sample of sedentary adolescents with overweight and obesity. After undergoing clinical, cardiovascular and anthropometric-metabolic evaluation (T0), subjects with overweight and obesity were randomized to a 6-month resistance or combined aerobic-resistance training program. Clinical, cardiovascular and anthropometric-metabolic evaluations were repeated after 6 months of training (T1) and after 3 months of detraining (T2). Thirty adolescents with overweight/obesity were enrolled and 20 subjects completed training program. A significant improvement in body composition was detected after 6 months, with a reduction of body mass index (32.1 [30.5 to 34.4] vs. 31.1 [29.6 to 33.4] kg/m
2 , p = 0.02) and adipose tissue (45.5 [41.1 to 49.7] vs. 41.6 [37.0 to 49.2] kg, p < 0.01). A reduction in diastolic blood pressure (75.5 ± 8.9 vs. 68.2 ± 6.4 mm Hg, p = 0.02) and pulse wave velocity (5.7 [5.1 to 5.9] vs. 5.2 [4.7 to 5.7] m/s, p = 0.04) was also observed. Persistence of the effect on the most important parameters was observed also after detraining period. In conclusion, regular physical exercise induces positive metabolic and cardiovascular effects, persisting even after brief discontinuation. Novelty: Physical exercise induces positive effect on cardiovascular risk profile. Positive effects persist also after brief discontinuation. Physical exercise reduces early signs of autonomic disfunction.- Published
- 2022
- Full Text
- View/download PDF
48. Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection.
- Author
-
Persu A, Lopez-Sublet M, Al-Hussaini A, Pappaccogli M, Radhouani I, Van der Niepen P, Adair W, Beauloye C, Brillet PY, Chan N, Chenu P, Devos H, Escaned J, Garcia-Guimaraes M, Hammer F, Jackson R, Jebri S, Kotecha D, Macaya F, Mahon C, Natarajan N, Neghal K, Nicol ED, Parke KS, Premawardhana D, Sajitha A, Wormleighton J, Samani NJ, McCann GP, and Adlam D
- Subjects
- Adult, Aneurysm diagnostic imaging, Aortic Dissection diagnostic imaging, Case-Control Studies, Computed Tomography Angiography, Coronary Vessel Anomalies genetics, Female, Fibromuscular Dysplasia diagnostic imaging, Humans, Magnetic Resonance Angiography, Male, Microfilament Proteins genetics, Middle Aged, Prevalence, United Kingdom epidemiology, Vascular Diseases epidemiology, Vascular Diseases genetics, Aneurysm epidemiology, Aortic Dissection epidemiology, Coronary Vessel Anomalies epidemiology, Fibromuscular Dysplasia epidemiology, Vascular Diseases congenital
- Abstract
Importance: Spontaneous coronary artery dissection (SCAD) has been associated with fibromuscular dysplasia (FMD) and other extracoronary arterial abnormalities. However, the prevalence, severity, and clinical relevance of these abnormalities remain unclear., Objective: To assess the prevalence and spectrum of FMD and other extracoronary arterial abnormalities in patients with SCAD vs controls., Design, Setting, and Participants: This case series included 173 patients with angiographically confirmed SCAD enrolled between January 1, 2015, and December 31, 2019. Imaging of extracoronary arterial beds was performed by magnetic resonance angiography (MRA). Forty-one healthy individuals were recruited to serve as controls for blinded interpretation of MRA findings. Patients were recruited from the UK national SCAD registry, which enrolls throughout the UK by referral from the primary care physician or patient self-referral through an online portal. Participants attended the national SCAD referral center for assessment and MRA., Exposures: Both patients with SCAD and healthy controls underwent head-to-pelvis MRA (median time between SCAD event and MRA, 1 [IQR, 1-3] year)., Main Outcome and Measures: The diagnosis of FMD, arterial dissections, and aneurysms was established according to the International FMD Consensus. Arterial tortuosity was assessed both qualitatively (presence or absence of an S curve) and quantitatively (number of curves ≥45%; tortuosity index)., Results: Of the 173 patients with SCAD, 167 were women (96.5%); mean (SD) age at diagnosis was 44.5 (7.9) years. The prevalence of FMD was 31.8% (55 patients); 16 patients (29.1% of patients with FMD) had involvement of multiple vascular beds. Thirteen patients (7.5%) had extracoronary aneurysms and 3 patients (1.7%) had dissections. The prevalence and degree of arterial tortuosity were similar in patients and controls. In 43 patients imaged with both computed tomographic angiography and MRA, the identification of clinically significant remote arteriopathies was similar. Over a median 5-year follow-up, there were 2 noncardiovascular-associated deaths and 35 recurrent myocardial infarctions, but there were no primary extracoronary vascular events., Conclusions and Relevance: In this case series with blinded analysis of patients with SCAD, severe multivessel FMD, aneurysms, and dissections were infrequent. The findings of this study suggest that, although brain-to-pelvis imaging allows detection of remote arteriopathies that may require follow-up, extracoronary vascular events appear to be rare.
- Published
- 2022
- Full Text
- View/download PDF
49. Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.
- Author
-
Persu A, Dobrowolski P, Gornik HL, Olin JW, Adlam D, Azizi M, Boutouyrie P, Bruno RM, Boulanger M, Demoulin JB, Ganesh SK, J Guzik T, Januszewicz M, Kovacic JC, Kruk M, de Leeuw P, Loeys BL, Pappaccogli M, Perik MHAM, Touzé E, Van der Niepen P, Van Twist DJL, Warchoł-Celińska E, Prejbisz A, and Januszewicz A
- Subjects
- Animals, Gene Expression Profiling trends, Genetic Predisposition to Disease, Hemodynamics, Humans, Phenotype, Predictive Value of Tests, Prognosis, Proteomics trends, Risk Assessment, Risk Factors, Vascular Remodeling, Arteries metabolism, Arteries pathology, Arteries physiopathology, Biomedical Research trends, Fibromuscular Dysplasia diagnosis, Fibromuscular Dysplasia genetics, Fibromuscular Dysplasia metabolism, Fibromuscular Dysplasia physiopathology, Molecular Diagnostic Techniques trends
- Abstract
Fibromuscular dysplasia (FMD) is a non-atherosclerotic vascular disease that may involve medium-sized muscular arteries throughout the body. The majority of FMD patients are women. Although a variety of genetic, mechanical, and hormonal factors play a role in the pathogenesis of FMD, overall, its cause remains poorly understood. It is probable that the pathogenesis of FMD is linked to a combination of genetic and environmental factors. Extensive studies have correlated the arterial lesions of FMD to histopathological findings of arterial fibrosis, cellular hyperplasia, and distortion of the abnormal architecture of the arterial wall. More recently, the vascular phenotype of lesions associated with FMD has been expanded to include arterial aneurysms, dissections, and tortuosity. However, in the absence of a string-of-beads or focal stenosis, these lesions do not suffice to establish the diagnosis. While FMD most commonly involves renal and cerebrovascular arteries, involvement of most arteries throughout the body has been reported. Increasing evidence highlights that FMD is a systemic arterial disease and that subclinical alterations can be found in non-affected arterial segments. Recent significant progress in FMD-related research has led to improve our understanding of the disease's clinical manifestations, natural history, epidemiology, and genetics. Ongoing work continues to focus on FMD genetics and proteomics, physiological effects of FMD on cardiovascular structure and function, and novel imaging modalities and blood-based biomarkers that can be used to identify subclinical FMD. It is also hoped that the next decade will bring the development of multi-centred and potentially international clinical trials to provide comparative effectiveness data to inform the optimal management of patients with FMD., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
50. A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring.
- Author
-
Avataneo V, Fanelli E, De Nicolò A, Rabbia F, Palermiti A, Pappaccogli M, Cusato J, De Rosa FG, D'Avolio A, and Veglio F
- Abstract
Objectives: Arterial hypertension is still the most frequent cause of cardiovascular and cerebrovascular morbidity and mortality. Antihypertensive treatment has proved effective in reduction of cardiovascular risk. Nevertheless, lifestyle interventions and pharmacological therapy in some cases are ineffective in reaching blood pressure target values, despite full dose and poly-pharmacological treatment. Poor adherence to medications is an important cause of treatment failure. Different methods to assess therapeutic adherence are currently available: Therapeutic drug monitoring in biological fluids has previously demonstrated its efficacy and reliability. Plasma and urine have been already used for this purpose, but they may be affected by some practical limitations. Saliva may represent a feasible alternative. Methods: Fourteen antihypertensive drugs and two metabolites were simultaneously tested in plasma, urine, and saliva. Tested molecules included: atenolol, nebivolol, clonidine, ramipril, olmesartan, telmisartan, valsartan, amlodipine, nifedipine, doxazosin, chlorthalidone, hydrochlorothiazide, indapamide, sacubitril, ramiprilat, and sacubitrilat. Therapeutic drug monitoring was performed using ultra-high performance liquid chromatography, coupled to tandem mass spectrometry (UHPLC-MS/MS). The method has been preliminarily evaluated in a cohort of hypertensive patients. Results: The method has been validated according to US Food and Drug Administration (FDA) and European Medicines Agency (EMA) guidelines. The application on a cohort of 32 hypertensive patients has demonstrated sensibility and specificity of 98% and 98.1%, respectively, with a good feasibility in real-life clinical practice. Conclusion: Saliva may represent a feasible biological sample for therapeutic drug monitoring by non-invasive collection, prompt availability, and potential accessibility also in out-of-clinic settings., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Avataneo, Fanelli, De Nicolò, Rabbia, Palermiti, Pappaccogli, Cusato, De Rosa, D'Avolio and Veglio.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.